RobertJSchilzDOPhD, FCCP

Pulmonology • Cleveland, OH

Critical Care Medicine, Pleural Disease

Associate Professor, Medicine, Case Western Reserve University School of Medicine

Join to view full profile

Dr. Schilz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schilz's full profile

Already have an account?

Office
11100 Euclid Ave
Cleveland, OH 44106
Phone+1 216-844-8500

Fax+1 216-844-2187

Education & Training

Yale-New Haven Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1993 - 1996
Cleveland Clinic FoundationResidency, Internal Medicine, 1989 - 1993
Michigan State University College of Osteopathic MedicineClass of 1988

Certifications & Licensure

OH State License 1990 - 2026
CT State License 1994 - 1996
MI State License 1988 - 1990

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Top MD Consumers Checkbook

Clinical Trials

Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Start of enrollment: 2011 Jun 01
Completed
Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
Completed
Phase 3
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension Start of enrollment: 2013 Sep 11
Completed
Phase 3
Beraprost-314d Added-on to Tyvaso® (BEAT) Start of enrollment: 2013 May 31
Completed
Phase 3
Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT Start of enrollment: 2014 May 31
Completed
Phase 2
S-Nitrosylation Therapy of COVID-19 Start of enrollment: 2021 Aug 05
Active, not recruiting
Early Phase 1
Join now to see all

Publications & Presentations

PubMed

187 citations
Treprostinil, a Prostacyclin Analogue, in Pulmonary Arterial Hypertension Associated With Connective Tissue Disease
Ronald J. Oudiz, Robert Schilz, Robyn J. Barst, Nazzareno Galiè, Stuart Rich
Chest. 2004-08-01
711 citations
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.
David B. Badesch, Victor F. Tapson, Michael D. McGoon, Bruce H. Brundage, Lewis J. Rubin
Annals of Internal Medicine. 2000-03-21
40 citations
The Prostacyclin Analogue Treprostinil Blocks NFκB Nuclear Translocation in Human Alveolar Macrophages
Baisakhi Raychaudhuri, Anagha Malur, Tracey L. Bonfield, Susamma Abraham, Robert Schilz
The Journal of Biological Chemistry. 2002-09-06

Professional Memberships

American Osteopathic Association - AOA
Member
American College of Physicians - ACP
Member